The Three Pillars of Topical Management for Allergic Dermatitis

Allergic dermatitis cases generate more topical product options than almost any other category in veterinary dermatology, which can make treatment planning feel overwhelming. In a recent Zarasyl-sponsored webinar, board-certified dermatologist Dr. Julia Miller, DVM, DACVD, offered a simple framework for organizing that decision-making: three pillars, addressed together rather than in isolation.

Pillar one: epidermal barrier support

Dr. Miller drew a direct comparison to human medicine, where moisturizing is a cornerstone of eczema and psoriasis management. Dogs and cats with atopic and environmental allergies are genetically predisposed to a defective epidermal barrier, and that defect works in both directions: it allows allergens to penetrate from the outside in, and it allows an already oversensitive immune response to make the barrier worse from the inside out.

She described this as a self-reinforcing cycle. A compromised barrier lets microbes and allergens through, which stimulates the immune system, which drives deeper inflammation, which further damages the barrier. Interrupting that cycle by supporting the barrier itself, through lipids, ceramides, essential fatty acids, and similar ingredients delivered in shampoos, sprays, mousses, spot-ons, and collars, was her first line of the framework.

Pillar two: inflammation management

For focal inflammatory lesions, Dr. Miller favors topical steroids, with a strong emphasis on choosing lower-potency options such as hydrocortisone for routine or preventive use. She was direct about the risk of overusing higher-potency steroids like betamethasone, cautioning that products intended for occasional focal use are frequently overapplied once they're in a client's hands, sometimes at a client's own initiative rather than at the prescribing doctor's direction.

Editorial note: this section touches on steroid potency and frequency guidance. Recommend confirming specific product and frequency claims against Zarasyl's labeling and standard derm references before publishing.

Pillar three: microbial management

The third pillar addresses the recurrent secondary bacterial and yeast infections that are common in allergic patients. Dr. Miller noted that a meaningful share of atopic dogs develop recurrent secondary bacterial infections, with a smaller subset developing secondary Malassezia, based on an older published study; she added that her own clinical experience suggests Malassezia is an even more frequent complication than that data reflects.

Her practical guidance: don't skip cytology. Confirming whether you're dealing with bacteria, yeast, both, or neither should happen before choosing a topical antimicrobial, not after.

Bringing the three pillars together

Dr. Miller's core message was that these three areas work best as a combined strategy rather than three separate decisions. A product that only manages microbes but ignores the barrier, for example, treats the immediate flare without addressing what's letting allergens and organisms in repeatedly. She encouraged looking for formulations that combine functions, such as antimicrobial shampoos or mousses that also contain ceramides for barrier support, when a patient needs both.

Watch the full session. This is one segment of a longer Zarasyl-sponsored dermatology webinar with Dr. Miller. Watch the full recording, including her live Q&A with attendees, at zarasyl.com/pages/webinars.

About the speaker

Dr. Julia Miller, DVM, DACVD, is a board-certified veterinary dermatologist with Animal Dermatology Group in Louisville, Kentucky. Her path into veterinary medicine included work as a farrier and in mixed animal practice before she became an award-winning educator and a widely recognized voice in veterinary dermatology. She is known for making dermatology practical and approachable for general practitioners and their teams.